256
Views
39
CrossRef citations to date
0
Altmetric
Original

Immunoadsorption in pemphigus

&
Pages 609-616 | Received 18 Jul 2006, Accepted 20 Jul 2006, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Silada Kanokrungsee, Tanaporn Anuntrangsee, Jutamas Tankunakorn, Ploychompoo Srisuwanwattana, Poonkiat Suchonwanit & Kumutnart Chanprapaph. (2021) Rituximab Therapy for Treatment of Pemphigus in Southeast Asians. Drug Design, Development and Therapy 15, pages 1677-1690.
Read now
Issam Hamadah, Muzamil A. Chisti, Mansoor Haider, Yousef Binamer, Saad Alajlan, Yousif Aleyouni & Abdullah Alfadley. (2019) Rituximab/IVIG in pemphigus – a 10-year study with a long follow-up. Journal of Dermatological Treatment 30:2, pages 170-175.
Read now
Khalaf Kridin. (2018) Emerging treatment options for the management of pemphigus vulgaris. Therapeutics and Clinical Risk Management 14, pages 757-778.
Read now
Sharon Baum, Sarit Gilboa, Shoshana Greenberger, Felix Pavlotsky, Henri Trau & Aviv Barzilai. (2013) Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases. Journal of Dermatological Treatment 24:6, pages 427-430.
Read now
Piercarlo Sarzi-Puttini & Andrea Doria. (2008) Organ specific-autoantibodies: Their role as markers and predictors of disease. Autoimmunity 41:1, pages 1-10.
Read now
Sergei A. Grando. (2006) Pemphigus in the XXI Century: New life to an old story. Autoimmunity 39:7, pages 521-530.
Read now

Articles from other publishers (33)

Connor Cole & Kyle Amber. (2022) Pemphigus for the Inpatient Dermatologist. Current Dermatology Reports 11:4, pages 221-232.
Crossref
Inga Koneczny, John Tzartos, Marina Mané-Damas, Vuslat Yilmaz, Maartje G. Huijbers, Konstantinos Lazaridis, Romana Höftberger, Erdem Tüzün, Pilar Martinez-Martinez, Socrates Tzartos & Frank Leypoldt. (2022) IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies. Frontiers in Immunology 13.
Crossref
Yen Loo Lim, Gerome Bohelay, Sho Hanakawa, Philippe Musette & Baptiste Janela. (2022) Autoimmune Pemphigus: Latest Advances and Emerging Therapies. Frontiers in Molecular Biosciences 8.
Crossref
Victor-Vlad Costan, Cristina Popa, Mădălina Hâncu, Elena Porumb‑Andrese & Mihaela Toader. (2021) Comprehensive review on the pathophysiology, clinical variants and management of pemphigus (Review). Experimental and Therapeutic Medicine 22:5.
Crossref
Tanja Fetter, Dennis Niebel, Christine Braegelmann & Joerg Wenzel. (2020) Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases—Implications for Therapeutic Approaches. Cells 9:12, pages 2627.
Crossref
Tomer Lagziel, Margarita Ramos, Grace F Rozycki, Charles S Hultman & Mohammed Asif. (2020) The First Reported Case of Metoprolol-Induced Pemphigus Foliaceus in the United States: A Critical Report and Review of Literature. Cureus.
Crossref
Sandra Saschenbrecker, Ingolf Karl, Lars Komorowski, Christian Probst, Cornelia Dähnrich, Kai Fechner, Winfried Stöcker & Wolfgang Schlumberger. (2019) Serological Diagnosis of Autoimmune Bullous Skin Diseases. Frontiers in Immunology 10.
Crossref
Dario Didona, Roberto Maglie, Rüdiger Eming & Michael Hertl. (2019) Pemphigus: Current and Future Therapeutic Strategies. Frontiers in Immunology 10.
Crossref
Kyle T. Amber, Roberto Maglie, Farzan Solimani, Rüdiger Eming & Michael Hertl. (2018) Targeted Therapies for Autoimmune Bullous Diseases: Current Status. Drugs 78:15, pages 1527-1548.
Crossref
Marwah Adly Saleh. (2018) A prospective study comparing patients with early and late relapsing pemphigus treated with rituximab. Journal of the American Academy of Dermatology 79:1, pages 97-103.
Crossref
Robert Pollmann, Thomas Schmidt, Rüdiger Eming & Michael Hertl. (2018) Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches. Clinical Reviews in Allergy & Immunology 54:1, pages 1-25.
Crossref
Matheus Negrao Pedroni, Camila Hirotsu, Adriana Maria Porro, Sergio Tufik & Monica Levy Andersen. (2017) The role of sleep in pemphigus: a review of mechanisms and perspectives. Archives of Dermatological Research 309:8, pages 659-664.
Crossref
Kyle Amber & Michael Hertl. 2017. Clinical and Basic Immunodermatology. Clinical and Basic Immunodermatology 767 774 .
Enno Schmidt & Richard Groves. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition 1 74 .
R. Eming. (2015) PemphigusPemphigus. Der Hautarzt 66:8, pages 574-582.
Crossref
Kyle T. Amber, Rüdiger Eming & Michael Hertl. 2015. Personalized Treatment Options in Dermatology. Personalized Treatment Options in Dermatology 135 146 .
Jaehwan Kim, Benjamin S. Daniel, Victoria P. Werth, Pascal Joly & Dédée F. Murrell. 2015. Blistering Diseases. Blistering Diseases 533 541 .
A. A. Kubanov & T. V. Abramova. (2014) Current methods of treatment of true acantholytic pemphigus. Vestnik dermatologii i venerologii 90:4, pages 19-27.
Crossref
Andreas Recke, Luisa M. Trog, Hendri H. Pas, Artem Vorobyev, Aida Abadpour, Marcel F. Jonkman, Ger van Zandbergen, Claudia Kauderer, Detlef Zillikens, Gestur Vidarsson & Ralf J. Ludwig. (2014) Recombinant Human IgA1 and IgA2 Autoantibodies to Type VII Collagen Induce Subepidermal Blistering Ex Vivo. The Journal of Immunology 193:4, pages 1600-1608.
Crossref
Cristina Has & Cassian Sitaru. 2013. Molecular Dermatology. Molecular Dermatology 1 16 .
M. Behzad, C. Möbs, A. Kneisel, M. Möller, J. Hoyer, M. Hertl & R. Eming. (2012) Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris. British Journal of Dermatology 166:4, pages 844-852.
Crossref
Michael Hertl & Rüdiger Eming. 2011. Autoimmune Diseases of the Skin. Autoimmune Diseases of the Skin 33 63 .
Hiromichi Yamada, Akira Itoh, Yoshihiro Hatanaka, Misuzu Tsukiji & Kenji Takamori. (2010) Screening and Analysis of Adsorbents for Pemphigus Autoantibodies. Therapeutic Apheresis and Dialysis 14:3, pages 292-297.
Crossref
M. Saha, A-M. Powell, B. Bhogal, M.M. Black & R.W. Groves. (2010) Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus. British Journal of Dermatology 162:4, pages 790-797.
Crossref
Oliver A. Perez & Timothy Patton. (2009) Novel Therapies for Pemphigus Vulgaris. Drugs & Aging 26:10, pages 833-846.
Crossref
Angela Nagel, Eva Podstawa, Markus Eickmann, Hans-Helge Müller, Michael Hertl & Rüdiger Eming. (2009) Rituximab Mediates a Strong Elevation of B-Cell-Activating Factor Associated with Increased Pathogen-Specific IgG but Not Autoantibodies in Pemphigus Vulgaris. Journal of Investigative Dermatology 129:9, pages 2202-2210.
Crossref
M. El-Darouti, S. Marzouk, R. Abdel Hay, A. El Tawdy, M. Fawzy, T. Leheta, H. Gammaz & N. Al Gendy. (2009) The use of sulfasalazine and pentoxifylline (low-cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study. British Journal of Dermatology 161:2, pages 313-319.
Crossref
Angela Nagel, Michael Hertl & Rüdiger Eming. (2009) B-Cell-Directed Therapy for Inflammatory Skin Diseases. Journal of Investigative Dermatology 129:2, pages 289-301.
Crossref
Donna A. Culton, Ye Qian, Ning Li, David Rubenstein, Valeria Aoki, Gunter Hans Filhio, Evandro A. Rivitti & Luis A. Diaz. (2008) Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: A paradigm of human autoimmunity. Journal of Autoimmunity 31:4, pages 311-324.
Crossref
Claudia Günther, Jörg Laske, Antje Frind, Ulrich Julius & Christiane Pfeiffer. (2008) Successful therapy of pemphigus vulgaris with immunoadsorption using the TheraSorb™ adsorber. Journal der Deutschen Dermatologischen Gesellschaft 6:8, pages 661-663.
Crossref
Victoria Ewan & Konrad Staines. (2008) Diagnosis and management of oral mucosal lesions in older people: a review. Reviews in Clinical Gerontology 18:2, pages 115-128.
Crossref
Björn P. Johansson, Oonagh Shannon & Lars Björck. (2008) IdeS: A Bacterial Proteolytic Enzyme with Therapeutic Potential. PLoS ONE 3:2, pages e1692.
Crossref
Michael Hertl & Rüdiger Eming. 2007. Fortschritte der praktischen Dermatologie und Venerologie 2006. Fortschritte der praktischen Dermatologie und Venerologie 2006 76 86 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.